AMEX · AMS

American Shared Hospital Services

$1.54 +$0.08 (+5.48%) 1D Market open

Key Metrics

$9.67M
Market cap
P/E · TTM
$29.05M
Revenue · TTM
−$1.54M
Net income
EPS · TTM $-0.23
Dividend yield
Free cash flow −$916.00K
Beta · 1Y -0.05
EBITDA · TTM
Gross margin 18.6%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 1
    The stock moved +17.2% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 1
  • Apr 14
    From its Feb 11 high, the share price fell 44%.

    Peak close $2.29 on Feb 11; trough close $1.29 on Apr 14. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -44%
  • Mar 31
    The stock moved -19.9% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 31

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$9.67M
Enterprise value$38.39M
Shares outstanding6.6M
52-wk range$1.25 – $3.11
Avg volume · 20D114.6K
Net cash −$28.71M
Book value / share$3.58
IndustryServices-Medical Laboratories
ExchangeAMEX
About American Shared Hospital Services
IPO dateSep 7, 1984
Employees84

American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy, and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.33
P/FCF
EV/EBITDA
EV/Sales1.32
Graham №

Profitability

Gross 18.6%
Operating -9.8%
Net -5.3%
FCF -3.2%
ROE / ROIC -6.3% · -5.3%

Financial Health

Current ratio0.77
Quick ratio
Debt / equity1.43
Debt / EBITDA
Net cash −$28.71M
Working capital−$5.45M

Cash Flow · TTM

Operating CF $2.74M
Capex −$3.66M
Free cash flow −$916.00K
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

0.5
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings